Atea Pharmaceuticals, Inc. (AVIR)
4.67
-0.06
(-1.27%)
USD |
NASDAQ |
May 29, 16:00
4.66
-0.01
(-0.21%)
After-Hours: 20:00
Atea Pharmaceuticals EPS Diluted (Quarterly) : -0.5738 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.2139 |
| CorMedix, Inc. | 0.4151 |
| Eloxx Pharmaceuticals, Inc. | -0.0779 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.0035 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.44M |
| Total Expenses (Quarterly) | 45.44M |
| Enterprise Value | 118.35M |
| Earnings Yield | -45.48% |
| Normalized Earnings Yield | -45.48 |